PRF Technologies Ltd.(PRFX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

PRFX PRF Technologies Ltd.

Post-Mkt 02-04 19:47:40 EST

0.6475

-0.0323

-4.75%

盘后0.6548

+0.0073+1.13%

19:47 EST

High0.6800	Low0.6249	Vol201.65K
Open0.6670	D1 Closing0.6798	Amplitude8.11%
Mkt Cap2.54M	Tradable Cap2.42M	Total Shares3.92M
T/O130.87K	T/O Rate5.40%	Tradable Shares3.74M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"PRFX","market":"US","secType":"STK","nameCN":"PRF Technologies Ltd.","latestPrice":0.6475,"timestamp":1770238800000,"preClose":0.6798,"halted":0,"volume":201654,"hourTrading":{"tag":"盘后","latestPrice":0.6548,"preClose":0.6475,"latestTime":"19:47 EST","volume":6404,"amount":4188.3261488,"timestamp":1770252432169,"change":0.0073,"changeRate":0.011274,"amplitude":0.020386},"delay":0,"changeRate":-0.047513974698440715,"floatShares":3736600,"shares":3915299,"eps":-1.0435876,"marketStatus":"Post-Mkt","change":-0.0323,"latestTime":"02-04 19:47:40 EST","open":0.667,"high":0.68,"low":0.6249,"amount":130868.0215074,"amplitude":0.081053,"askPrice":0.655,"askSize":12,"bidPrice":0.65,"bidSize":7,"shortable":3,"etf":0,"ttmEps":-1.0435876,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1770253200000},"marketStatusCode":4,"adr":0,"listingDate":1598932800000,"exchange":"NASDAQ","adjPreClose":0.6798,"preHourTrading":{"tag":"盘前","latestPrice":0.69,"preClose":0.6798,"latestTime":"09:27 EST","volume":3892,"amount":2717.5806322,"timestamp":1770215227468,"change":0.0102,"changeRate":0.015004,"amplitude":0.05178},"postHourTrading":{"tag":"盘后","latestPrice":0.6548,"preClose":0.6475,"latestTime":"19:47 EST","volume":6404,"amount":4188.3261488,"timestamp":1770252432169,"change":0.0073,"changeRate":0.011274,"amplitude":0.020386},"volumeRatio":1.149873},"requestUrl":"/m/hq/s/PRFX","defaultTab":"news","newsList":[{"id":"2608839653","title":"Prf Technologies Ltd: to Effect Reverse Share Split of Co’s Ordinary Shares at Ratio of 1-for-5","url":"https://stock-news.laohu8.com/highlight/detail?id=2608839653","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608839653?lang=en_us&edition=fundamental","pubTime":"2026-02-04 05:35","pubTimestamp":1770154531,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260203:nFWN3YZ17P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PRFX","BK4007"],"gpt_icon":0},{"id":"2608388605","title":"PRF Technologies Announces 1-for-5 Reverse Stock Split","url":"https://stock-news.laohu8.com/highlight/detail?id=2608388605","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608388605?lang=en_us&edition=fundamental","pubTime":"2026-02-04 05:17","pubTimestamp":1770153458,"startTime":"0","endTime":"0","summary":"PRF Technologies Ltd. announced a 1-for-5 reverse share split of its ordinary shares, effective February 6, 2026, on the Nasdaq Capital Market. After the split, the number of issued and outstanding ordinary shares will be reduced from 3,915,340 to 783,068, with all fractional shares rounded up to the nearest whole share. The company's authorized share capital will consist of 12,000,000 ordinary shares, and a proportionate adjustment will be made to outstanding warrants and options. The new CUSIP number for the ordinary shares will be M77798201.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. PRF Technologies Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retri","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260203:nNDL9wY7zj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PRFX","BK4007"],"gpt_icon":0},{"id":"2604119547","title":"PRF Technologies Unveils Patent for Micro-Climate Solar Forecasting Software","url":"https://stock-news.laohu8.com/highlight/detail?id=2604119547","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604119547?lang=en_us&edition=fundamental","pubTime":"2026-01-20 22:06","pubTimestamp":1768917978,"startTime":"0","endTime":"0","summary":"PRF Technologies Ltd. has announced the filing of a patent application for proprietary methods in solar plant-level micro-climate modeling, aimed at significantly improving the accuracy of solar energy production forecasts. The technology, which underpins the company's DeepSolar Predict software platform, addresses limitations in conventional forecasting by incorporating highly localized weather data for more precise short-term and intraday predictions. PRF Technologies believes this advancement can help utility-scale solar operators optimize energy dispatch, manage risk, and enhance financial performance. The results and details of this technology were announced as part of the patent filing, but there is no indication that they have been or will be presented at a scientific conference.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for i","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260120:nNDL1Dc9Pd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3QW5Z07.USD","IE00BKPKM429.USD","SG9999014021.USD","BK4585","PRFX","LU2210149790.SGD","LU2095319765.USD","LU2210150020.SGD","BK4588","BK4007","SG9999014005.SGD","BK4112","SG9999014013.SGD","SG9999014039.USD","LU0314104364.USD","IE00B64PRP62.GBP","IE00BGHQF748.EUR","NDAQ"],"gpt_icon":0},{"id":"2603619699","title":"Why PainReform Shares Are Trading Higher By 27%; Here Are 20 Stocks Moving Premarket","url":"https://stock-news.laohu8.com/highlight/detail?id=2603619699","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603619699?lang=en_us&edition=fundamental","pubTime":"2026-01-16 17:38","pubTimestamp":1768556280,"startTime":"0","endTime":"0","summary":"Shares of PainReform Ltd.  rose sharply in pre-market trading.The company announced a name change amid its expansion diversified healthcare and AI-driven energy platforms.PainReform shares jumped 27.4% to $1.02 in the pre-market trading session.Here are some other stocks moving in pre-market trading.","market":"sh","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/01/16/Section-Of-A-Financial-Newspaper-Titled-.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/01/16/Section-Of-A-Financial-Newspaper-Titled-.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/news/26/01/49958427/why-painreform-shares-are-trading-higher-by-27-here-are-20-stocks-moving-premarket","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/26/01/49958427/why-painreform-shares-are-trading-higher-by-27-here-are-20-stocks-moving-premarket","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["PRFX","BK4007"],"gpt_icon":0},{"id":"2603359069","title":"PainReform Ltd - Announces Corporate Name Change to Prf Technologies Ltd, Nasdaq Ticker Symbol to Remain Prfx","url":"https://stock-news.laohu8.com/highlight/detail?id=2603359069","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603359069?lang=en_us&edition=fundamental","pubTime":"2026-01-16 05:11","pubTimestamp":1768511509,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260115:nFWN3YG0UH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","PRFX"],"gpt_icon":0},{"id":"2603354779","title":"PainReform changes name to PRF Technologies","url":"https://stock-news.laohu8.com/highlight/detail?id=2603354779","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603354779?lang=en_us&edition=fundamental","pubTime":"2026-01-16 05:10","pubTimestamp":1768511429,"startTime":"0","endTime":"0","summary":"PainReform announced its corporate name change to PRF Technologies following shareholder approval at the company’s annual general meeting. The comp...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/painreform-changes-name-to-prf-technologies-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/painreform-changes-name-to-prf-technologies-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PRF","PRFX","BK4585","BK4007","BK4588"],"gpt_icon":0},{"id":"2603987935","title":"PainReform Ltd. Changes Name to PRF Technologies Ltd","url":"https://stock-news.laohu8.com/highlight/detail?id=2603987935","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603987935?lang=en_us&edition=fundamental","pubTime":"2026-01-16 05:05","pubTimestamp":1768511106,"startTime":"0","endTime":"0","summary":"PainReform Ltd. has changed its name to PRF Technologies Ltd., reflecting its expansion into diversified healthcare and AI-driven energy platforms. The company's Nasdaq ticker symbol remains PRFX.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. PainReform Ltd. published the original content used to generate this news brief via GlobeNewswire  on January 15, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260115:nNDL8YS0Fs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","SG9999014013.SGD","LU2210149790.SGD","SG9999014021.USD","BK4585","LU2210150020.SGD","PRFX","IE00BKPKM429.USD","SG9999014039.USD","IE00B3QW5Z07.USD","IE00B64PRP62.GBP","LU0314104364.USD","NDAQ","BK4112","SG9999014005.SGD","LU2095319765.USD","IE00BGHQF748.EUR","BK4007"],"gpt_icon":0},{"id":"2603935989","title":"Press Release: PainReform Ltd. Changes Name to PRF Technologies Ltd. Reflecting Expansion into Diversified Healthcare and AI-Driven Energy Platforms","url":"https://stock-news.laohu8.com/highlight/detail?id=2603935989","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603935989?lang=en_us&edition=fundamental","pubTime":"2026-01-16 05:05","pubTimestamp":1768511100,"startTime":"0","endTime":"0","summary":"TEL AVIV, Israel, Jan. 15, 2026  -- PRF Technologies Ltd.    today announced its corporate name change to PRF Technologies Ltd. following shareholder approval at the Company's Annual General Meeting held on Tuesday, January 6, 2026. The Company's Nasdaq ticker symbol will remain PRFX.The approved name change is intended to reflect the Company's evolution into a diversified innovation platform spanning specialty pharmaceuticals, advanced drug-delivery technologies, and AI-driven renewable-energy analytics, marking a strategic shift beyond its original single-product focus.Over the past 18 months, PRF has significantly broadened its portfolio across multiple large, high-growth markets. While the Company continues to advance PRF-110, its non-opioid extended-release postoperative pain therapy, it has also established two additional growth platforms through LayerBio and DeepSolar, each supported by differentiated technology and independent market opportunity.\"This name change reflects how f","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4099","TM","BK4587","XLV","BK4588","BK4543","BK4528","PRFX","PRF","BK4555","BK4581","LU0128526141.USD","LU0029874061.USD","BK4551","03160","LABU","BK4137","BK4023","BK4604","XBI","BK4585","HCSG","AI"],"gpt_icon":0},{"id":"2602462055","title":"PainReform Reports Positive Phase I Safety Data for OcuRing-K Ocular Drug Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2602462055","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602462055?lang=en_us&edition=fundamental","pubTime":"2026-01-12 22:37","pubTimestamp":1768228670,"startTime":"0","endTime":"0","summary":"The latest update is out from PainReform ( ($PRFX) ). On January 12, 2026, PainReform and its majority-owned subsidiary LayerBio reported that thei...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/painreform-reports-positive-phase-i-safety-data-for-ocuring-k-ocular-drug-platform?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/painreform-reports-positive-phase-i-safety-data-for-ocuring-k-ocular-drug-platform?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","PRFX"],"gpt_icon":0},{"id":"2602754308","title":"PainReform Ltd - Announces Safety Data for Ocuring™-K Development","url":"https://stock-news.laohu8.com/highlight/detail?id=2602754308","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602754308?lang=en_us&edition=fundamental","pubTime":"2026-01-12 22:04","pubTimestamp":1768226661,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nFWN3YD0QP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","PRFX"],"gpt_icon":0},{"id":"2602543036","title":"PainReform Ltd - Preclinical Studies Show Favorable Tolerability for Ocuring™-K","url":"https://stock-news.laohu8.com/highlight/detail?id=2602543036","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602543036?lang=en_us&edition=fundamental","pubTime":"2026-01-12 22:04","pubTimestamp":1768226661,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nFWN3YD0QP:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PRFX","BK4007"],"gpt_icon":0},{"id":"2602543742","title":"PainReform’s OcuRing-K Platform Shows Favorable Safety in Phase I Clinical Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2602543742","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602543742?lang=en_us&edition=fundamental","pubTime":"2026-01-12 22:02","pubTimestamp":1768226537,"startTime":"0","endTime":"0","summary":"PainReform Ltd. and its majority-owned subsidiary, LayerBio, Inc., have announced safety data from the development program of the OcuRing-K drop-less, sustained-release ocular drug delivery platform intended for use in cataract surgery. The program included a series of preclinical rabbit studies and a Phase I clinical study in patients undergoing cataract surgery. The results from these studies, which have already been presented, demonstrated a favorable safety profile for the platform, supporting its continued advancement toward later-stage clinical development.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. PainReform Ltd. published the original content used to generate this news brief via GlobeNewswire  on January 12, 2026, and is s","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nNDL1JRPVB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3QW5Z07.USD","LU2095319765.USD","LU2210150020.SGD","IE00BGHQF748.EUR","SG9999014021.USD","SG9999014005.SGD","BK4112","LU0314104364.USD","BK4588","NDAQ","SG9999014039.USD","BK4007","BK4585","IE00B64PRP62.GBP","IE00BKPKM429.USD","LU2210149790.SGD","PRFX","SG9999014013.SGD"],"gpt_icon":0},{"id":"2601314843","title":"PainReform Ltd. held shareholder meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2601314843","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601314843?lang=en_us&edition=fundamental","pubTime":"2026-01-07 05:16","pubTimestamp":1767734168,"startTime":"0","endTime":"0","summary":"PainReform Ltd. held its Adjourned Annual General Meeting of Shareholders on January 6, 2026. All six proposals brought before the shareholders at the meeting were approved.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. PainReform Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on January 06, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260106:nNDL6fFPsT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","PRFX"],"gpt_icon":0},{"id":"2601882839","title":"DeepSolar Launches Smart TDD to Boost Global Solar Asset Due Diligence","url":"https://stock-news.laohu8.com/highlight/detail?id=2601882839","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601882839?lang=en_us&edition=fundamental","pubTime":"2026-01-05 22:00","pubTimestamp":1767621613,"startTime":"0","endTime":"0","summary":"PainReform Ltd.'s DeepSolar Launches Smart TDD, Revolutionizing Global Solar Asset Due Diligence. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. PainReform Ltd. published the original content used to generate this news brief via GlobeNewswire  on January 05, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260105:nNDL7qcZ3S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LU0314104364.USD","BK4112","BK4585","LU2210149790.SGD","IE00B3QW5Z07.USD","IE00B64PRP62.GBP","LU2095319765.USD","SG9999014021.USD","SG9999014013.SGD","BK4007","IE00BKPKM429.USD","LU2210150020.SGD","NDAQ","PRFX","SG9999014005.SGD","IE00BGHQF748.EUR","SG9999014039.USD"],"gpt_icon":0},{"id":"2590158705","title":"PainReform Confirms LayerBio Ocular Platform Can Deliver Multiple Drugs in Sustained-Release Form","url":"https://stock-news.laohu8.com/highlight/detail?id=2590158705","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590158705?lang=en_us&edition=fundamental","pubTime":"2025-12-10 21:30","pubTimestamp":1765373408,"startTime":"0","endTime":"0","summary":"PainReform Ltd. has announced the completion of a research and development assessment of LayerBio's proprietary drop-less, sustained-release ocular drug-delivery platform. The results confirm that the platform's sustained-release polymer matrix can incorporate a variety of drug entities. This finding supports the platform's long-term potential to improve pharmacological efficiency and simplify postoperative care for cataract patients by reducing or eliminating the need for medicated eye drops. The results were announced by the company and have not been specified as already presented or scheduled to be presented at a future event.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. PainReform Ltd. published the original content used to gener","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251210:nNDL1GC1qT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3QW5Z07.USD","IE00BKPKM429.USD","SG9999014021.USD","BK4585","PRFX","LU2210149790.SGD","LU2095319765.USD","LU2210150020.SGD","BK4588","BK4007","SG9999014005.SGD","BK4112","SG9999014013.SGD","SG9999014039.USD","LU0314104364.USD","IE00B64PRP62.GBP","IE00BGHQF748.EUR","NDAQ"],"gpt_icon":0},{"id":"2588141059","title":"BRIEF-Painreform Commences Development For Ocuring™-K Phase II Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2588141059","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588141059?lang=en_us&edition=fundamental","pubTime":"2025-12-02 22:19","pubTimestamp":1764685168,"startTime":"0","endTime":"0","summary":"BRIEF-Painreform Commences Development For Ocuring-K Phase II TrialDec 2 (Reuters) - PainReform Ltd PRFX.O:PAINREFORM COMMENCES DEVELOPMENT FOR OCURING-K PHASE II TRIAL, LAYERBIO’S DROP-LESS SUSTAINED","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251202:nTUA8LJ8X4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","PRFX"],"gpt_icon":0},{"id":"2588596050","title":"PainReform Advances Drop-Less OcuRing-K Therapy Toward Phase II Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2588596050","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588596050?lang=en_us&edition=fundamental","pubTime":"2025-12-02 22:15","pubTimestamp":1764684911,"startTime":"0","endTime":"0","summary":"PainReform Ltd. has announced the commencement of its development plan for OcuRing-K, an innovative, drop-less, sustained-release ocular therapy designed to deliver controlled ketorolac following cataract surgery. The company, in collaboration with LayerBio, is advancing OcuRing-K toward a Phase II clinical trial in the United States. The initial target indication is for post-cataract pain and inflammation, with the goal of providing consistent control with significantly lower drug exposure than traditional eye drops. The research and development efforts are ongoing, and future updates will be provided as the program progresses. No specific scientific research results have been presented yet; the results will be generated and shared following the next stages of clinical development.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for infor","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251202:nNDL3fn5n6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NDAQ","IE00BKPKM429.USD","BK4007","BK4588","BK4585","IE00B64PRP62.GBP","LU2210149790.SGD","LU0314104364.USD","LU2210150020.SGD","IE00B3QW5Z07.USD","LU2095319765.USD","BK4112","PRFX","IE00BGHQF748.EUR"],"gpt_icon":0},{"id":"2588305963","title":"PainReform Commences Development for Ocuring™-K Phase Ii Trial, Layerbio’s Drop-Less Sustained-Release Ocular Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2588305963","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588305963?lang=en_us&edition=fundamental","pubTime":"2025-12-02 22:15","pubTimestamp":1764684900,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251202:nTUA8LJ8X4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PRFX","BK4007"],"gpt_icon":0},{"id":"2586940122","title":"PainReform Ltd. Announces December 2025 Shareholders Meeting with Key Proposals","url":"https://stock-news.laohu8.com/highlight/detail?id=2586940122","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586940122?lang=en_us&edition=fundamental","pubTime":"2025-11-26 05:54","pubTimestamp":1764107682,"startTime":"0","endTime":"0","summary":"The latest announcement is out from PainReform ( ($PRFX) ). On November 25, 2025, PainReform Ltd. announced its upcoming Annual General Meeting of ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/painreform-ltd-announces-december-2025-shareholders-meeting-with-key-proposals?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/painreform-ltd-announces-december-2025-shareholders-meeting-with-key-proposals?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","PRFX"],"gpt_icon":0},{"id":"2586409152","title":"PainReform Ltd. Announces Date for Upcoming Annual General Meeting of Shareholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2586409152","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586409152?lang=en_us&edition=fundamental","pubTime":"2025-11-26 05:16","pubTimestamp":1764105392,"startTime":"0","endTime":"0","summary":"PainReform Ltd. has announced that it will hold its Annual General Meeting of Shareholders on December 30, 2025, at the offices of its attorneys in Tel Aviv, Israel. During the meeting, shareholders will be asked to approve the re-election of Dr. Ehud Geller to the Board of Directors as a Class I director. They will also vote on a proposal to change the company's name from \"PainReform Ltd.\" to \"PRF Ltd.\" and amend the company's articles of association accordingly, subject to regulatory approval. Additionally, shareholders will consider the approval of a grant of options to Asaf Shavit, a member of the Board of Directors.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. PainReform Ltd. published the original content used to generate this ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251125:nNDL945FMQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","PRFX"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.painreform.com","stockEarnings":[{"period":"1week","weight":-0.0726},{"period":"1month","weight":-0.0273},{"period":"3month","weight":-0.393},{"period":"6month","weight":-0.4869},{"period":"1year","weight":-0.7749},{"period":"ytd","weight":0.0592}],"compareEarnings":[{"period":"1week","weight":-0.0086},{"period":"1month","weight":0.0093},{"period":"3month","weight":0.0176},{"period":"6month","weight":0.0906},{"period":"1year","weight":0.1535},{"period":"ytd","weight":0.0112}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"PainReform Ltd., a clinical stage specialty pharmaceutical company, engages in the development of therapeutics that provides an extended period of post-surgical pain relief in Israel. The company engages in developing PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia. It is currently conducting Phase 3 clinical trials of PRF-110 for the treatment of patients undergoing bunionectomy surgery and hernia repair. The company was incorporated in 2007 and is based in Tel Aviv, Israel.","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.0371},{"month":2,"riseRate":0.5,"avgChangeRate":0.092162},{"month":3,"riseRate":0.4,"avgChangeRate":-0.068689},{"month":4,"riseRate":0.2,"avgChangeRate":-0.216174},{"month":5,"riseRate":0,"avgChangeRate":-0.142442},{"month":6,"riseRate":0.4,"avgChangeRate":-0.0782},{"month":7,"riseRate":0.4,"avgChangeRate":-0.022654},{"month":8,"riseRate":0.4,"avgChangeRate":-0.15911},{"month":9,"riseRate":0.2,"avgChangeRate":-0.17317},{"month":10,"riseRate":0,"avgChangeRate":-0.160968},{"month":11,"riseRate":0.5,"avgChangeRate":-0.020834},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.071991}],"exchange":"NASDAQ","name":"PRF Technologies Ltd.","nameEN":"PRF Technologies Ltd."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"PRF Technologies Ltd.(PRFX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest PRF Technologies Ltd.(PRFX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"PRF Technologies Ltd.,PRFX,PRF Technologies Ltd.股票,PRF Technologies Ltd.股票老虎,PRF Technologies Ltd.股票老虎国际,PRF Technologies Ltd.行情,PRF Technologies Ltd.股票行情,PRF Technologies Ltd.股价,PRF Technologies Ltd.股市,PRF Technologies Ltd.股票价格,PRF Technologies Ltd.股票交易,PRF Technologies Ltd.股票购买,PRF Technologies Ltd.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"PRF Technologies Ltd.(PRFX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest PRF Technologies Ltd.(PRFX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}